The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Mylan; Pfizer; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; MSD Oncology (Inst); Mylan; Pfizer; Roche; Sanofi; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche
Dynamics and type of ESR1 mutations under aromatase inhibitor or fulvestrant combined with palbociclib after randomization in the PADA-1 trial.
 
Luc Cabel
No Relationships to Disclose
 
Suzette Delaloge
Consulting or Advisory Role - AstraZeneca (Inst); Besins Healthcare (Inst); Gilead Sciences (Inst); Rappta Therapeutics (Inst); Sanofi (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis (Inst); Pfizer
 
Anne-Claire Hardy-Bessard
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; GlaxoSmithKline; MSD; Novartis; Pfizer; Seagen
 
Fabrice Andre
Stock and Other Ownership Interests - PEGASCY
Consulting or Advisory Role - Gilead Sciences (Inst); Guardant Health (Inst); MEDIMMUNE (Inst); Relay therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Daiichi (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Thomas Bachelot
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; pfizer; Roche
 
Ivan Bieche
No Relationships to Disclose
 
Celine Callens
No Relationships to Disclose
 
Anne Pradines
No Relationships to Disclose
 
Florian Clatot
Honoraria - AstraZeneca; AstraZeneca; BMS; BMS; BMS; Merck; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD
Consulting or Advisory Role - BMS; Lilly; Lilly; Merck Serono; Merck Serono; MSD; Novartis; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; BMS; Merck Serono; Novartis; Novartis; Pfizer; Roche
 
Thibault De La Motte Rouge
No Relationships to Disclose
 
Jean-Luc Re Canon
Honoraria - AstraZeneca/Daiichi Sankyo; Lilly; Seagen
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Sanofi; Seagen
Research Funding - Bristol-Myers Squibb/Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Roche/Genentech
 
Laurent Arnould
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Florence Dalenc
No Relationships to Disclose
 
Renaud Sabatier
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novartis
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Jean-Marc Ferrero
Honoraria - Exact ciences; Novartis
Consulting or Advisory Role - Daichi; Novartis; Pfizer
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Alain Lortholary
Honoraria - AstraZeneca; clovis oncology; MSD; Novartis; Roche; Tesaro/GSK; Tesaro/GSK
 
Jerome Lemonnier
No Relationships to Disclose
 
Frederique Berger
No Relationships to Disclose
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; GE Healthcare; GlaxoSmithKline; Lilly; Menarini; Novartis; Pfizer; Rain Oncology; Sanofi (Inst)
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Menarini Group; Novartis; Pfizer; Rain Oncology; Roche
Research Funding - GE Healthcare (Inst); Menarini Silicon Biosystems (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Prolynx (Inst)
Patents, Royalties, Other Intellectual Property - ESR1 & MSI detection techniques (patents) (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer; Roche